Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10018193HBVENSG00000082556.14protein_codingOPRK1NoNo4986P41145
TVIS20013017HPVENSG00000082556.14protein_codingOPRK1NoNo4986P41145
TVIS20021008HPVENSG00000082556.14protein_codingOPRK1NoNo4986P41145
TVIS20013016HPVENSG00000082556.14protein_codingOPRK1NoNo4986P41145
TVIS20062745HPVENSG00000082556.14protein_codingOPRK1NoNo4986P41145
TVIS44020000HTLV-1ENSG00000082556.14protein_codingOPRK1NoNo4986P41145
TCGA Plot Options
Drug Information
GeneOPRK1
DrugBank IDDB00704
Drug NameNaltrexone
Target IDBE0000632
UniProt IDP41145
Regulation Typeantagonist
PubMed IDs11752352; 18354714; 9040115; 17661275; 19484223
CitationsChen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.@@Helm S, Trescot AM, Colson J, Sehgal N, Silverman S: Opioid antagonists, partial agonists, and agonists/antagonists: the role of office-based detoxification. Pain Physician. 2008 Mar-Apr;11(2):225-35.@@Herz A: Endogenous opioid systems and alcohol addiction. Psychopharmacology (Berl). 1997 Jan;129(2):99-111.@@Barrios de Tomasi E, Juarez-Gonzalez J: [Opioid antagonists and alcohol consumption]. Rev Neurol. 2007 Aug 1-15;45(3):155-62.@@Wee S, Orio L, Ghirmai S, Cashman JR, Koob GF: Inhibition of kappa opioid receptors attenuated increased cocaine intake in rats with extended access to cocaine. Psychopharmacology (Berl). 2009 Sep;205(4):565-75. doi: 10.1007/s00213-009-1563-y. Epub 2009 May 30.
GroupsApproved; Investigational; Vet_approved
Direct ClassificationPhenanthrenes and derivatives
SMILES[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O
PathwaysNaltrexone Action Pathway
PharmGKBPA450588
ChEMBLCHEMBL19019